Table 2a. The top 50 unique genes upregulated in lesional skin compared with non-lesional skin biopsy samples obtained at baseline from 85 patients with moderate-to-severe psoriasis (FDR P<0.05 and FCH >2).
Mean expression in skin samples |
||||||
---|---|---|---|---|---|---|
Probe set ID | Gene symbol | Gene title | Fold change (lesional vs. non-lesional) | Non- lesional | Lesional | Cytokine regulation1 |
205863_at | S100A12 | S100 calcium–binding protein A12 | 889.1 | 2.72 | 12.52 | IL-17, TNF-α, IFN-γ, A |
211906_s_at | SERPINB4 | Serpin peptidase inhibitor, clade B (ovalbumin), member 4 | 740.44 | 3.76 | 13.30 | IL-17, S |
205513_at | TCN1 | Transcobalamin I (vitamin B12–binding protein, R binder family) | 400.17 | 2.95 | 11.60 | |
232220_at | S100A7A | S100 calcium–binding protein A7A | 287.22 | 5.15 | 13.32 | S |
220664_at | SPRR2C | Small proline-rich protein 2C (pseudogene) | 243.3 | 3.62 | 11.55 | IL-17, A |
205660_at | OASL | 2′-5′-Oligoadenylate synthetase-like | 238.28 | 3.15 | 11.04 | IFN-γ |
207602_at | TMPRSS11D | Transmembrane protease, serine 11D | 199.6 | 2.89 | 10.53 | S |
1569555_at | GDA | Guanine deaminase | 168.79 | 3.44 | 10.84 | |
210663_s_at | KYNU | Kynureninase (L-kynurenine hydrolase) | 153.53 | 2.75 | 10.02 | TNF-α, S |
207367_at | ATP12A | ATPase, H+/K+ transporting, nongastric, α-polypeptide | 148.59 | 3.93 | 11.15 | A |
220528_at | VNN3 | Vanin 3 | 144.45 | 2.23 | 9.40 | S |
210413_x_at | SERPINB3/SERPINB4 | Serpin peptidase inhibitor, clade B (ovalbumin), member 3/serpin peptidase inhibitor, clade B (ovalbumin), member 4 | 136.5 | 6.86 | 13.95 | |
206561_s_at | AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | 114.33 | 6.19 | 13.03 | |
202859_x_at | IL8 | interleukin 8 | 105.05 | 2.82 | 9.54 | IL-17, TNF-α, S |
205783_at | KLK13 | Kallikrein-related peptidase 13 | 94.62 | 4.16 | 10.73 | |
219554_at | RHCG | Rh family, C glycoprotein | 74.17 | 5.51 | 11.72 | IL-17, TNF-α, A |
204470_at | CXCL1 | Chemokine (C–X–C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 72.33 | 2.45 | 8.63 | IL-17, TNF-α, IFN-γ, S |
1554914_at | PLA2G4D | Phospholipase A2, group IVD (cytosolic) | 66.91 | 2.75 | 8.81 | |
205476_at | CCL20 | Chemokine (C–C motif) ligand 20 | 64.89 | 2.93 | 8.95 | IL-17, TNF-α, S |
219403_s_at | HPSE | Heparanase | 63.46 | 6.14 | 12.13 | |
216258_s_at | SERPINB13 | Serpin peptidase inhibitor, clade B (ovalbumin), member 13 | 61.38 | 3.25 | 9.19 | |
210164_at | GZMB | Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | 60.46 | 2.93 | 8.85 | |
232074_at | PRSS27 | Protease, serine 27 | 56.4 | 4.33 | 10.15 | |
204733_at | KLK6 | Kallikrein-related peptidase 6 | 51.71 | 6.79 | 12.48 | |
205844_at | VNN1 | Vanin 1 | 50.72 | 4.41 | 10.08 | |
210038_at | PRKCQ | Protein kinase C, theta | 48.3 | 2.54 | 8.14 | |
206912_at | FOXE1 | Forkhead box E1 (thyroid transcription factor 2) | 46.38 | 2.92 | 8.45 | S |
239430_at | IGFL1 | IGF-like family member 1 | 46.06 | 4.77 | 10.30 | |
220322_at | IL1F9 | Interleukin 1 family, member 9 | 45.99 | 7.82 | 13.34 | IL-17, TNF-α, IFN-γ, A |
209719_x_at | SERPINB3 | Serpin peptidase inhibitor, clade B (ovalbumin), member 3 | 45.81 | 8.96 | 14.48 | IFN-γ(−), S |
212531_at | LCN2 | Lipocalin 2 | 45.74 | 7.96 | 13.47 | IL-17, TNF-α, IFN-γ(−), A |
224204_x_at | ARNTL2 | Aryl hydrocarbon receptor nuclear translocator-like 2 | 43.67 | 4.03 | 9.48 | |
213797_at | RSAD2 | Radical S-adenosyl methionine domain containing 2 | 41.39 | 5.03 | 10.40 | IFN-γ |
233504_at | C9orf84 | Chromosome 9 open reading frame 84 | 40.75 | 3.70 | 9.05 | |
227735_s_at | C10orf99 | Chromosome 10 open reading frame 99 | 40.71 | 7.78 | 13.13 | |
203535_at | S100A9 | S100 calcium–binding protein A9 | 40.71 | 9.25 | 14.60 | IL-17, TNF-α, IFN-γ, A |
226698_at | FCHSD1 | FCH and double SH3 domains 1 | 39.37 | 5.42 | 10.72 | |
220249_at | HYAL4 | Hyaluronoglucosaminidase 4 | 39.25 | 4.25 | 9.55 | |
202134_s_at | WWTR1 | WW domain containing transcription regulator 1 | 36.95 | 4.69 | 9.89 | TNF-α(−), IFN-γ(−) |
206134_at | ADAMDEC1 | ADAM-like, decysin 1 | 36.28 | 4.32 | 9.50 | |
241994_at | XDH | Xanthine dehydrogenase | 35.21 | 3.41 | 8.55 | IFN-γ |
1553434_at | CYP4Z2P | Cytochrome P450, family 4, subfamily Z, polypeptide 2 pseudogene | 34.49 | 2.22 | 7.33 | |
227609_at | EPSTI1 | Epithelial stromal interaction 1 (breast) | 34.32 | 3.77 | 8.87 | |
206008_at | TGM1 | Transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-γ-glutamyltransferase) | 34.05 | 5.62 | 10.71 | TNF-α, IFN-γ, A |
219691_at | SAMD9 | Sterile α-motif domain containing 9 | 33.57 | 4.43 | 9.50 | IFN-γ |
240304_s_at | TMC5 | Transmembrane channel-like 5 | 33.52 | 3.11 | 8.18 | |
221107_at | CHRNA9 | Cholinergic receptor, nicotinic, α-9 | 32.35 | 3.19 | 8.21 | |
204465_s_at | INA | Internexin neuronal intermediate filament protein, alpha | 31.67 | 3.85 | 8.83 | |
239586_at | FAM83A | Family with sequence similarity 83, member A | 31.29 | 5.43 | 10.40 | |
209773_s_at | RRM2 | Ribonucleotide reductase M2 polypeptide | 31.19 | 5.71 | 10.67 | IFN-γ(−) |
Abbreviations: FCH, fold change; FDR, false discovery rate; TNF, tumor necrosis factor.
Genes that are induced by IL-17, IFN-γ, and TNF-α in keratinocytes and yield a synergistic (S) or additive (A) effect between IL-17 and TNF on keratinocytes (Nograles et al., 2008; Chiricozzi et al., 2011).